Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01485731 · ClinicalTrials.gov registry record · Phase 1
Safety Study of Nelfinavir + Cisplatin + Pelvic Radiation Therapy to Treat Cervical Cancer
A Phase 1 study, sponsored by University of Miami.
- Completed
- Registry status
- Phase 1
- Development phase
- 8
- Enrollment target
NCT01485731 is a Phase 1 study that has completed, run by University of Miami. The registered enrollment target is 8 participants.
The verdict
NCT01485731, a Phase 1 study, has completed, sponsored by University of Miami.
- COMPLETED
- Registry status
- Phase 1
- Development phase
- 8 participants
- Enrollment target
Study Summary
Nelfinavir will increase the efficacy of Cisplatin based chemo- radiation therapy for locally advanced cervical cancer.
Interventions
- DRUG Cisplatin
- RADIATION Brachytherapy
- DRUG Nelfinavir
- RADIATION Pelvic External Beam Radiation Therapy
- PROCEDURE Pharmacokinetic Sampling
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 8 participants |
| Start Date | 2012-01 |
| Est. Completion | 2015-02 |
| Phase | Phase 1 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01485731
The ClinicalTrials.gov registry entry for NCT01485731 describes a study currently listed as completed, categorized as Phase 1. The registered enrollment target is 8 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Miami, which has 721 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 5 interventions - of which Cisplatin is the first listed.
NCT01485731 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01485731 about?
NCT01485731 is a clinical study titled "Safety Study of Nelfinavir + Cisplatin + Pelvic Radiation Therapy to Treat Cervical Cancer". Nelfinavir will increase the efficacy of Cisplatin based chemo- radiation therapy for locally advanced cervical cancer.
What is the current status of trial NCT01485731?
This trial is currently completed. It is a Phase 1 study. The enrollment target is 8 participants. The study started on 2012-01. Estimated completion is 2015-02.
What interventions are being tested in trial NCT01485731?
The interventions under investigation include: Cisplatin (DRUG), Brachytherapy (RADIATION), Nelfinavir (DRUG), Pelvic External Beam Radiation Therapy (RADIATION), Pharmacokinetic Sampling (PROCEDURE).
Who is sponsoring clinical trial NCT01485731?
This trial is sponsored by University of Miami, which has 721 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.